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Antifungal activityAbstract There are many human oral antimicrobial peptides responsible for playing important
roles including maintenance, repairing of oral tissues (hard or soft) and defense against oral
microbes. In this review we have highlighted the biochemistry, physiology and proteomics of human
oral histatin peptides, secreted from parotid and submandibular salivary glands in human. The sig-
niﬁcance of these peptides includes capability for ionic binding that can kill fungal Candida albicans.
They have histidine rich amino acid sequences (7–12 family members; corresponding to residues
12–24, 13–24, 12–25, 13–25, 5–11, and 5–12, respectively) for Histatin-3. However, Histatin-3 can
be synthesized proteolytically from histatin 5 or 6. Due to their fungicidal response and high
biocompatibility (little or no toxicity), these peptides can be considered as therapeutic agents with
most probable applications for example, artiﬁcial saliva for denture wearers and salivary gland
dysfunction conditions. The objectives of current article are to explore the human histatin peptides
for its types, chemical and biological aspects. In addition, the potential for therapeutic bio-dental
applications has been elaborated.
 2016 The Authors. Production and Hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Journal
2 Z. Khurshid et al.Contents
1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2. Histatin peptides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
3. Role of histatin peptides in human oral cavity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
4. Histatin and advances in bio-dental research . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
5. Conclusion and recommendations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
References. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 001. Introduction
The signiﬁcance and beneﬁcial roles of organic macro-
molecules isolated from human body secretions are well
known. Human peptides are secreted physiologically by cer-
tain organs such as salivary glands (Trindade et al., 2015;
Kota´l et al., 2015) or by pathologically by diseased tissues such
as ameloblastoma (Jhamb and Kramer, 2014; Vered et al.,
2003; Garg et al., 2015). In last few decades, a number of
major developments such as better understanding and advent
of proteomic tools started helping in isolation of protein based
material from human secretions for example lysozyme
(Sabatini et al., 1990), a-defensin, b-defensin, cathelicidins
(Selsted et al., 1985), histatin family (Oppenheim et al.,
1988), statherin, granulysin, thrombocidin-1, chemokine
CCL20, psoriasin S100A7, neuropeptide (Dawidson et al.,
1996), substance P and dermcidin (Zasloff, 2002). Reported
secretions that have been mainly utilized included blood,
lymph, saliva, glands secretion (endocrine and exocrine
glands), urine, and body ﬂuids (Schrader and Schulz-
Knappe, 2001; Hu et al., 2006). Proteomics is a discovery
science technology that helped categorizing genomics sequenc-
ing, physiology, microarray analysis and metabolite proﬁling
of proteins and peptides (Cellulaire, 2002). Commonly used
proteomic instruments are two-dimensional (2D) gel elec-
trophoresis, liquid chromatography (LC), mass spectrometry
with electrospray ionization (ESI), and matrix-assisted laser
desorption ionization (MALDI) coupled with time of ﬂight
(TOF) (Gorg et al., 2004; Wittmann-Liebold et al., 2006).
These techniques and instruments can be used for the anal-
ysis of body ﬂuids. For example, in case of oral and dental
health, human saliva can be analyzed to differentiate between
diseased and healthy patients without any surgical interven-
tions (De Smet and Contreras, 2005). Saliva contains a vast
number of protein species. The salivary peptidome (low molec-
ular weight) comprises approximately 40–50% of the total
secreted proteins in addition to peptides generated by proteol-
ysis of proteins from different sources (Vitorino et al., 2004;
Hu et al., 2005; Loo et al., 2010; Thomadaki et al., 2011).
The timeline of human salivary proteins and peptides identiﬁ-
cation is listed in Table 1 (Hu et al., 2005; Piludu et al., 2006;
Wong, 2006; Rudney et al., 2009). Up till now, more than 1165
types of salivary proteins have been identiﬁed and reported in
human salivary proteome central depository (http://www.skb.
ucla.edu/cgi-bin/hspmscgi-bin/welcome_c.cgi) supported by
National Institute of Dental and Craniofacial Research
(NIDCR). The objectives of current article are to explore the
human histatin peptides for its types, chemical and biological
aspects. In addition, the potential for therapeutic bio-dental
applications has been elaborated.Please cite this article in press as: Khurshid, Z. et al., Histatin peptides: Pharmacolog
(2016), http://dx.doi.org/10.1016/j.jsps.2016.04.0272. Histatin peptides
Histatin peptides belong to a family of antimicrobial peptides
that are rich in histidine amino acids. The ﬁrst ever histatin
was isolated from human parotid salivary gland secretions in
1988 (Oppenheim et al., 1988). Histidine rich polypeptides
have been proven to have antimicrobial and antifungal proper-
ties (VAN et al., 1997). They are secreted by major salivary
glands including parotid and submandibular glands. The con-
centration of histatin peptides in saliva ranges from 50 to
425 lg/ml (VAN et al., 1997). Based on chemistry and
sequence of amino acids, there are variety of histatin peptides.
The common variants of natural histatins found in saliva are
Histatin-1 (38 amino acids; Mw  4929 Da), histatin-3 (32
amino acids; Mw  4063 Da) and Histatin-5 (24 amino acids;
Mw  3037 Da) (Sabatini and Azen, 1989; Raj et al., 1990;
Troxler et al., 1990). Histatin-1 and Histatin-3 are derived
from the available genes HTN1 and HTN3 present in humans
(Table 2) (VAN et al., 1997). Histatin-5 is originated from par-
ent peptide i.e. histatin-3 and contains N-terminal that is
thought to be highly reactive and highly afﬁnitive to bond with
metals. The chemical nature leads to precipitate reactive oxy-
gen species (Nikawa et al., 2002; Cabras et al., 2007).
The analysis of Amino acid sequence of 12 histatin peptides
(Table 3) suggested that histatin-2 is primarily degradable pro-
duct of histatin-1. On the other hand, remaining histatins are
proteolytic product of histatin-3. Considering the fact that his-
tatins are humans own defense peptides, these peptides have
gained popularity in the ﬁeld of therapeutic and biodental
medicine. In addition, the antimicrobial drugs containing nat-
ural peptides prevent resistance development against patho-
gens such as bacteria, fungi, viruses and parasites (De Smet
and Contreras, 2005; Ryley, 2001; Wang, 2014).
3. Role of histatin peptides in human oral cavity
We are very well aware of the protective role of saliva that aids
in digestion, lubrication, protection, and host defense immu-
nization of the oral cavity (Dawes et al., 2015). These processes
are made possible due to its unique composition and chem-
istry. Human saliva bio-ﬂuid instead of blood can be used as
disease biomarkers for diagnosis and therapeutic targets. In
addition, it has major beneﬁts of being cost effective and
non-invasive not causing any pain or discomforts
(Thomadaki et al., 2011; Halgand et al., 2012). Human saliva
contains various forms of anti-microbial polypeptides that
play few vital roles such as innate immunity and combating
against invading foreign pathogens (Lamkin and Oppenheim,
1993), wound healing (Oudhoff et al., 2008), and apoptosis
(Rudney et al., 2009). Among various peptides, histatin hasical functions and their applications in dentistry. Saudi Pharmaceutical Journal
Table 1 Timeline of human salivary protein (http://aps.unmc.edu/AP/).
Proteins and
peptides
Year Amino
acids
Functions
Statherin 1977 43 Potent inhibitor of calcium phosphate precipitation
a-Defensins
(HNP-1-4)
1985 <50 Antibacterial, antifungal and antiviral activities because of six cysteine disulﬁde bonds
Histatin-1 1988 38 Responsible for maintenance of oral hemostasis, role in forming acquired tooth pellicle and help in
bonding of some metal ions
Histatin-3 1988 32 Responsible for maintenance of oral hemostasis, role in forming acquired tooth pellicle and help in
bonding of some metal ions
Histatin-5 1988 24 Responsible for maintenance of oral hemostasis, role in forming acquired tooth pellicle and help in
bonding of some metal ions
Adrenomedullin 1993 52 Mitogenic, inducible, vasodilator and antibacterial peptide
b-Defensins
(hBD-1)
1995 36–47 Poor antibacterial activity, antiviral and antifungal activity, Also help in tissue repair
Cathelicidins
(LL-37)
1995 37 Chemo-attractant to immune cells and act as ‘‘alarmin” by inducing immune response
b-Defensins
(hBD-2)
1997 41 Antibacterial against Gram-negative and Gram-positive, antiviral and antifungal activity against HIV
b-Defensins
(hBD-3)
2001 45 Antibacterial against Gram-negative and Gram-positive, also drug resistant microbes, chemo-attractant
antiviral and antifungal activity
C-C motif
Chemokine 28
2008 128 Act as chemokine, salt sensitive and broad spectral antibacterial
Azurocidin 251 Strong antibacterial activity against Gram-negative bacteria
Neuropeptides 1997 – They have ﬁve types; Substance P (SP), Neurokinin A (NKA), Calcitonin Gene
Related Peptide (CGRP), Neuropeptide Y (NPY) and Vasoactive Intestinal
Polypeptide (VIP), eﬀective against Candida albicans and bacteria
Calprotectin 1999 93–114 Act as calcium sensors and potent zinc binder, also play role in tissue repair
Mucins 1990 3750 Aggregate oral ﬂora bacteria and prevent dental caries
Table 2 Representing the gene encoding series of human
histatin family.
Allele Gene Protein
HIS1 HTN1 Histatin-1
HIS2 HTN3 Histatin-3 – histatin-4 to -6
Histatin peptides and applications 3been targeted and gained quite interests in ﬁeld of biodental
research utilizing proteomics approach (Khurshid et al.,
2016; Siqueira et al., 2012). The eminent forms of human his-
tatins are Histatin-1, Histatin-3 and Histatin-5 with individual
contribution of around 20–30% to the total histatin pool. The
theorized functions of histatin are buffering (Amado, 2005),
wound healing (Kavanagh and Dowd, 2004), anti-candidal
(Tsai and Bobek, 1998), antiviral (Nikawa et al., 2002),
antibacterial (Cabras et al., 2007; Ryley, 2001) and balance
of minerals formation (Wang, 2014).
In 2011 McDonald et al. worked on Histatin-1 and studied
the composition, structure and function of acquired enamel
pellicle. The key role of Histatin-1 absorbed by hydroxyapatite
crystals was to protect from proteolytic degradation and dem-
ineralization (McDonald et al., 2011). Histatin 1 comprises
phosphorylated serine at number 2 residue that increases afﬁn-
ity of the peptide to bind with HA crystals (Yin et al., 2003).
One of the distinctive features of human oral mucosa is that,
it has a high turnover rate. Hence, this characteristic is consid-
ered due to the presence of many factors such as presence of
Histatin-1 and Histatin-2. These peptides indirectly induced
wound healing by stimulating epithelial migration (OudhoffPlease cite this article in press as: Khurshid, Z. et al., Histatin peptides: Pharmacolog
(2016), http://dx.doi.org/10.1016/j.jsps.2016.04.027et al., 2008). In comparison, the epithelial growth factor
(EGF) and nerve growth factor (NGF) have been reported less
stable in terms of wound healing compared to histatins
(Oudhoff et al., 2009; Sun et al., 2009).
In recent years, certain valuable researches concerning the
effects of histatin on Candida albicans have been performed
and reported (Tsai et al., 1996; Tsai and Bobek, 1997a;
Edgerton et al., 1998). It has been investigated and found that
all three major types of histatin peptides (Histatin-1, Histatin-3
and Histatin-5) have the capability to inhibit and kill candidal
organisms however, varies in their abilities to kill blastoconidia
and germinated cells. In comparison, Histatin-5 has been
reported as most active, Histatin-3 being moderately active
and His-1 being least active (Xu et al., 1991). Due to this phar-
macological nature, histatin is attractive candidate for thera-
peutic products. The reported mechanism by which histatin
acts as fungistatic and fungicidal agent includes disruption of
plasma membrane, which leads to the loss of intracellular com-
ponents (Oppenheim et al., 1988). It was also found that his-
tatins were also effective in killing of yeast by damaging its
membrane (due to release of potassium) by binding to the
Trk1 potassium transporter and hence loss of intracellular,
and azole-resistant fungal species (Fig. 1) (Tsai and Bobek,
1997b; Swidergall and Ernst, 2014). In acquired immuno deﬁ-
ciency syndrome (AIDS), the amount of histatin was found to
be decreased and hence it is suggested that they can be used as
a biomarker for diagnosis (Khan et al., 2013).
Antimicrobial potential of histatin peptides has been dis-
cussed above. This can better be explained by knowing its
structure. His-3 and His-5 have capacity to bind to metals,
due to the presence of reactive N-terminal (Tay et al., 2009).ical functions and their applications in dentistry. Saudi Pharmaceutical Journal
Table 3 Histatin Family with their proteolytic fragments (Khurshid et al., 2015).
Human histatins Sequences
Histatin 1 DSpHEKRHHGYRRKFHEKHHSHREFPFYGDYGSNYLYDN
Histatin 3 DSHAKRHHGYKRKFHEKHHSHRGYRSNYLYDN
Histatin 5 DSHAKRHHGYKRKFHEKHHSHRGY
Proteolytic fragments in saliva
Histatin 2 RKFHEKHHSHREFPFYGDYGSNYLYDN
Histatin 4 KFHEKHHSHRGYRSNYLYDN
Histatin 6 DSHAKRHHGYKRKFHEKHHSHRGYR
Histatin 7 RKFHEKHHSHRGY
Histatin 8 KFHEKHHSHRGY
Histatin 9 RKFHEKHHSHRGYR
Histatin 10 KFHEKHHSHRGYR
Histatin 11 KRHHGYKR
Histatin 12 KRHHGYK
Figure 1 Mechanism of action of human histatin peptides against Candida albicans.
4 Z. Khurshid et al.Herein, this N-terminal has high potential to bind with the
metals especially copper and nickel, thus generating reactive
oxygen species which damages membranes of cell organelles,
also may damage the DNA and hence leads to the fungal
and bacterial cell death (Harford and Sarkar, 1997; Grogan
et al., 2001). Bacteriodes gingivalis, one of the important micro
ﬂoras of the oral cavity is associated with the destruction of the
periodontium as it produces proteases (Gusman et al., 2001).
In addition, effects of histatin peptides on secreted proteases
and clostripain have been investigated (Imatani et al., 2000).Please cite this article in press as: Khurshid, Z. et al., Histatin peptides: Pharmacolog
(2016), http://dx.doi.org/10.1016/j.jsps.2016.04.027It was concluded that Histatin-5 inhibited the activity of pro-
teases and clostripain (clostridiopeptidase B, Clostridium his-
tolytium proteinase B). It binds to the protease active sites
making non-covalent complexes, therefore playing a key role
in preventing the periodontitis (Nishikata et al., 1991). The
antiviral property of histatins was also investigated; however,
little is known about it. There is need of further research to
better understand the three dimensional structure of histatin
and to rule out which salivary polypeptide is responsible for
antiviral activity (Hardestam et al., 2008).ical functions and their applications in dentistry. Saudi Pharmaceutical Journal
Histatin peptides and applications 54. Histatin and advances in bio-dental research
The ability of histatin in inhibiting fungal infections can be
observed in patients suffering from xerostomia, since they
are most susceptible of acquiring infections. Therefore his-
tatins can be used in medicines to help in preventing such
infections (Tati et al., 2014). In denture wearers where their
immunity is compromised it was observed that they were prone
to opportunistic pathogens such as C. albicans (Farah et al.,
2000; Samaranayake and Samaranayake, 2001). Experimenta-
tion was done to see the effect of growth of candidal species on
polymethyl methacrylate (PMMA) and it was demonstrated
that histatins inhibited the growth of these microorganisms
(Vukosavljevic et al., 2012). Thus, this can be utilized as a pow-
erful tool in prevention and as a therapeutic agent in minimiz-
ing the possibilities of getting fungal infections (Peters et al.,
2010; Iqbal and Zafar, 2016).
There are a number of potential clinical applications for
using histatin peptides as a therapeutic agent. As previously
mentioned, histatin peptides are playing an effective role in bind-
ing to hydroxyapatite crystals. Familiar with this phenomenon,
it can be used as a reagent in materials to prevent abrasion and
wearing off enamel (Yin et al., 2003; Ullah and Zafar, 2015).
Recently, the prime functions of histatins in the ﬁeld of pep-
tidomics as demonstrated were applied in dental implants for
the prevention of implantitis that is considered as one of the
important causes of failure of dental implants (Holmberg
et al., 2013). The surface of titanium implant was modiﬁed by
conjoining antimicrobial with titanium-binding peptides, which
resulted in decreased formation of bioﬁlm (Yoshinari et al.,
2010) and reduced adherence of microorganisms such as Pseu-
domonas gingivalis on the sub gingival and supra gingival sur-
faces of implants (Yoshinari et al., 2010; Yeo et al., 2012).5. Conclusion and recommendations
Histatin peptides are the key elements of antimicrobial pep-
tides that have bactericidal and anti-inﬂammatory activities
(Helmerhorst et al., 2001). One of the drawbacks of histatin
to be used in drugs as a therapeutic agent was that they were
not stable against proteolysis (Sabatini et al., 1989). After
studying metallo-peptide nature of histatin and its morphol-
ogy, we are very well aware of the fact that they have potential
to form bond with metal ions especially with copper and nickel
at a physiological pH (Cabras et al., 2007). This property can
greatly be used in terms of histatin binding to these metals. In
addition, histatin becomes more stable and resistant to prote-
olysis hence, can be used in drugs to combat against oral
pathogens (Zawisza et al., 2014).References
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